<DOC>
	<DOC>NCT00460733</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of risedronate sodium (ActonelÂ®) after a wrist fracture in postmenopausal women.</brief_summary>
	<brief_title>SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.</brief_title>
	<detailed_description />
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Colles' Fracture</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Women with description of 2 or more years of Menopause; Tscore &lt;= 2.0 sd; Confirmed colles'fracture; Independent for the march (preserved ambulatorial ability); Comorbidities; Regular use of corticosteroids or other antiresorptive drug in the last year; Use of drugs that can affect the calcium metabolism; Hypersensitivity to risedronate; Previous wrist or forearm fracture; Hypocalcemia; Renal insufficiency; Rheumatic disease; The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>